DICP OpenIR
Comprehensive lipid profiling of plasma in patients with benign breast tumor and breast cancer reveals novel biomarkers
Yang, Li1; Cui, Xinge1,2,3; Zhang, Ningning4,5; Li, Min1; Bai, Yu1; Han, Xiaohong4,5; Shi, Yuankai4,5; Liu, Huwei1
关键词Breast Cancer Benign Breast Tumor Lipidomics Biomarker Np/rp 2dlc-ms
刊名ANALYTICAL AND BIOANALYTICAL CHEMISTRY
2015-07-01
DOI10.1007/s00216-015-8484-x
407期:17页:5065-5077
收录类别SCI
文章类型Article
WOS标题词Science & Technology ; Life Sciences & Biomedicine ; Physical Sciences
类目[WOS]Biochemical Research Methods ; Chemistry, Analytical
研究领域[WOS]Biochemistry & Molecular Biology ; Chemistry
关键词[WOS]PROTEIN-KINASE-C ; LC-QTOF-MS ; MASS-SPECTROMETRY ; GLUCOSYLCERAMIDE SYNTHASE ; QUANTITATIVE-ANALYSIS ; CELLS ; METABOLISM ; RESISTANCE ; CERAMIDE ; PHOSPHOLIPIDS
英文摘要Abnormal lipid metabolism is a common feature in most solid tumors, and occurs in early stages of the tumor progression. As benign breast tumor is different from malignant tumor of breast cancer, it is particularly important to take benign breast tumor into consideration when investigating cancer biomarkers. In this study, by using a normal-phase/reversed-phase two-dimensional liquid chromatography-mass spectrometry (NP/RP 2D LC-MS) method, we conducted comprehensive lipid profiling in human plasma obtained from six benign breast tumor patients and five breast cancer patients, as well as nine healthy controls. As a result, 512 lipid species were successfully identified. Principal component analysis allowed clear separation of the three groups. Quantitative analysis revealed that many lipid contents were similar in benign and malignant breast tumors compared with controls, and these were proposed as potential breast tumor biomarkers other than breast cancer biomarkers. Two phosphatidylinositol (PI) species, including PI (16:0/16:1) and PI (18:0/20:4), could differentiate between benign and malignant breast tumors, as well as breast cancer patients and healthy controls, indicating that they could be utilized as potential breast cancer biomarkers. In addition, PI (16:0/18:1), phosphatidylglycerol (36:3), and glucosylceramide (d18:1/15:1) were demonstrated to be potential biomarkers to evaluate the level of malignancy of breast tumor. Taken together, our results indicate the usefulness of lipid profiling in the discrimination between patients with breast cancer and non-carcinoma lesions, which might provide assistance in clinical diagnosis.
语种英语
WOS记录号WOS:000356461800017
引用统计
文献类型期刊论文
条目标识符http://cas-ir.dicp.ac.cn/handle/321008/146323
专题中国科学院大连化学物理研究所
作者单位1.Peking Univ, Beijing Natl Lab Mol Sci, Key Lab Bioorgan Chem & Mol Engn, Inst Analyt Chem,Coll Chem & Mol Engn,Minist Educ, Beijing 100871, Peoples R China
2.Beijing Union Med Coll Hosp, Clin Pharmacol Res Ctr, Beijing 100730, Peoples R China
3.Chinese Acad Med Sci, Beijing 100730, Peoples R China
4.Peking Union Med Coll, Canc Inst & Hosp, Dept Med Oncol, Beijing 100021, Peoples R China
5.Chinese Acad Med Sci, Beijing 100021, Peoples R China
推荐引用方式
GB/T 7714
Yang, Li,Cui, Xinge,Zhang, Ningning,et al. Comprehensive lipid profiling of plasma in patients with benign breast tumor and breast cancer reveals novel biomarkers[J]. ANALYTICAL AND BIOANALYTICAL CHEMISTRY,2015,407(17):5065-5077.
APA Yang, Li.,Cui, Xinge.,Zhang, Ningning.,Li, Min.,Bai, Yu.,...&Liu, Huwei.(2015).Comprehensive lipid profiling of plasma in patients with benign breast tumor and breast cancer reveals novel biomarkers.ANALYTICAL AND BIOANALYTICAL CHEMISTRY,407(17),5065-5077.
MLA Yang, Li,et al."Comprehensive lipid profiling of plasma in patients with benign breast tumor and breast cancer reveals novel biomarkers".ANALYTICAL AND BIOANALYTICAL CHEMISTRY 407.17(2015):5065-5077.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Yang, Li]的文章
[Cui, Xinge]的文章
[Zhang, Ningning]的文章
百度学术
百度学术中相似的文章
[Yang, Li]的文章
[Cui, Xinge]的文章
[Zhang, Ningning]的文章
必应学术
必应学术中相似的文章
[Yang, Li]的文章
[Cui, Xinge]的文章
[Zhang, Ningning]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。